Peter Jahrling, PhD
Dr. Jahrling is Chief Scientist at the National Institute of Allergy and Infectious Diseases, Integrated Research Facility, and Chief of the Emerging Viral Pathogens Section where the major areas of research involve the development of animal models for human diseases involving Category A viral pathogens; the evaluation of immunization strategies and therapeutic interventions based on antiviral drugs, passive immunization, and targeted reversal of pathophysiological processes; and the isolation and characterization of viral agents associated with previously uncharacterized diseases (pathogen discovery).
Dr. Jahrling received his PhD in medical microbiology from Cornell Medical College. Upon graduation, he served as an Army officer at the U.S. Army Medical Research Institute of Infectious Diseases, where he specialized in viral hemorrhagic fevers requiring biosafety level (BSL)-4 containment. After fulfillment of his military obligation, Dr. Jahrling converted to civilian status and was eventually appointed scientific advisor for the institute. In 2005, Dr. Jahrling accepted appointments as chief scientist of the NIAID Integrated Research Facility in Frederick, Maryland, and chief of the Emerging Viral Pathogens Section.